Orgenesis Inc.
corporate_fare Company Profile
Orgenesis Inc. (OTC:ORGS) is a publicly traded company in the Healthcare sector. Wiseek has independently scored 4 items for ORGS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-04-15, rated 9/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for ORGS spans PRE 14A, 10-K, 8-K.
Recent high-impact activity:
- Orgenesis Seeks Shareholder Approval for Highly Dilutive Financing to Address Going Concern
- Orgenesis Inc. Reports Substantial Doubt About Going Concern, Nasdaq Delisting, and Significant Dilutive Financing
- Orgenesis Divests Global Ranpirnase IP and Development Assets to Okogen
- Orgenesis Issues Warrants for 3.29M Shares at Deep Discount as Part of Financing
Financial Snapshot
Short Interest & Short Volume
1.24 days to coverFINRA reported short interest of 5,258 shares in ORGS as of the October 30, 2026 settlement, unchanged from the prior period — about 1.2 days to cover at its recent average daily volume. On November 17, 2026, 15.2% of ORGS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.